Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JMS CoTSE:7702 55 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates TSE:7702 with a GF Score™ of 55/100 and a GF Value™ of 円509.13 (Modestly Undervalued). The stock has 9 warning signs investors should review. Among 825 Medical Devices & Instruments companies, JMS Co ranks worse than 57.7% on this metric.
The historical rank and industry rank for JMS Co's OCF Margin % or its related term are showing as below:
TSE:7702'
s OCF Margin % Range Over the Past 10 Years
Min: 2.1 Med: 5.45 Max: 8.41
Current: 2.42
During the past 13 years, the highest OCF Margin % of JMS Co was 8.41%. The lowest was 2.10%. And the median was 5.45%.
TSE:7702's OCF Margin % is ranked worse than 57.7% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: 6.52
vs TSE:7702: 2.42
The historical data trend for JMS Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7702 vs ISRG, BDX, RMD: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, JMS Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMS Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMS Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where JMS Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMS Co (TSE:7702) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on JMS Co and its competitors. Over the past decade, JMS Co's OCF Margin % has ranged from 2.10 to 8.41. According to the industry distribution chart, JMS Co ranks #476 out of 825 companies in the Medical Devices & Instruments industry, placing it in the top 57.7%.
Is JMS Co's OCF Margin % too high?
JMS Co's current OCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 2.10 to a high of 8.41. Based on the distribution chart, JMS Co ranks #476 out of 825 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, JMS Co has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does JMS Co's OCF Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMS Co ranks #476 out of 825 companies for OCF Margin %. This places JMS Co in the lower half of its industry. The industry median OCF Margin % is 6.52. Historically, JMS Co's own OCF Margin % has ranged from 2.10 to 8.41 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 6.52, based on 825 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on JMS Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 6.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMS Co's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMS Co stock overvalued right now?
Based on GuruFocus' analysis, JMS Co (TSE:7702) is currently considered Modestly Undervalued. The stock's GF Value™ is 円509.13, compared to a current price of 円456.00 — trading 10.4% below its estimated fair value. The current OCF Margin % is 0.00%. JMS Co's overall GF Score™ is 55/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For JMS Co (TSE:7702), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMS Co (TSE:7702) Overvalued in 2026?
Based on GuruFocus' analysis, JMS Co stock appears to be undervalued.
The current stock price of 円456.00 is trading 10.4% below its estimated GF Value™ of 円509.13.
GuruFocus considers JMS Co to be Modestly Undervalued.
Key valuation signals for TSE:7702:
OCF Margin %: 0.00%
GF Value™: 円509.13 vs. price of 円456.00 (10.4% below fair value)
No single metric tells the full story. See the TSE:7702 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMS Co Ltd is a Japan-based medical equipment manufacturer. The company is engaged in the manufacture, sale, export, and import of medical equipment and pharmaceuticals. Products offered by the company include an infusion pump, syringe pump, surgical gown, peritoneal dialysate, dialyzer, mask cap, sheet for treatment, pacemaker, heat exchanger, blood bag, among others. JMS has network operations in various countries including Europe, North America, Asia, the Middle East, Latin America and Africa.
55GF Score
Get the complete analysis for TSE:7702
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7702 has been successfully added to your 
